Comparison of two cytoreductive regimens for αβ-T-cell-depleted haploidentical HSCT in pediatric malignancies: Improved engraftment and outcome with TBI-based regimen.
Elad JacobyNira Varda-BloomGal GoldsteinDaphna HuttChaim ChuriHelly VernitskyAmos TorenBella BieloraiPublished in: Pediatric blood & cancer (2017)
A TBI-based conditioning for haplo-HSCT using αβ-T-cell depletion for malignant diseases ensured engraftment and resulted in acceptable outcomes.